NSDHL
protein-codingNAD(P) dependent steroid dehydrogenase-like, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~38.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010441
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010621
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010621
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010441
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010621
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010441
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010621
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010441
Submitter: ClinGen
NSDHL variants have been reported in the literature in association with CHILD syndrome (Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects, MIM: 308050, MONDO: 0010621) and CK syndrome (MIM: 300831, MONDO: 0010441), characterized by delayed psychomotor development, intellectual disability, seizures, microcephaly, and dysmorphic features. NSDHL loss-of-function (LoF) variants cause CHILD syndrome in females and are usually lethal in males, while NSDHL hypomorphic variants cause CK syndrome in males and female carriers are typically unaffected. Thus far, neurodevelopmental disorders such as intellectual disability or seizures have not been reported in individuals with a diagnosis of CHILD syndrome (PMIDs: 26014843, 16088165, 25533639, 15689440, 16549711, 25093865, 21753784, 29341259) but have been observed in CK syndrome. For this reason, the ID/Autism Gene Curation Expert Panel has opted to evaluate this gene’s relationship to CK syndrome; evidence related to NSDHL and CHILD syndrome is not considered here. Variants in NSDHL have thus far only been reported in 3 multigenerational families with the CK syndrome presentation; affected males share consistent features of intellectual disability, seizures, microcephaly, and dysmorphic facial features. Reported variants include a frameshift in the last exon resulting in stop loss and extension (PMID: 19377476), and an in-frame deletion of a single amino acid in the original CK family (PMID: 21129721), both shown to be hypomorphic alleles (PMID: 21129721); and a missense variant with no functional studies (PMID: 25900314). Supportive segregation data is available in all three families. This gene-disease association is also supported by experimental evidence. NSDHL encodes an enzyme in the cholesterol biosynthesis pathway and patient-derived lymphoblastoid cells have increased methyl sterol levels similar to those observed in CHILD syndrome (PMID: 21129721). Additional support is provided by a mouse model exhibiting abnormal cortical development (PMID: 21129721). In summary, there is moderate evidence supporting an association between NSDHL and X-linked CK syndrome. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 1/20/21 (SOP Version 8).
Inheritance Pattern: XL
Disease ID:MONDO:0010621
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Dermatologic; Musculoskeletal; Pulmonary; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NSDHL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015922.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 44 | 11 | 72 | ||
| missense | 2 | 7 | 127 | 39 | 6 | 181 |
| nonsense | 6 | 5 | 11 | |||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 5 | |||
| splice donor/acceptor (+/-2bp) | 1 | 16 | 17 | |||
| Total | 11 | 10 | 165 | 83 | 17 | 286 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057006.1 | 7 | MANE Select | |
| Ensembl | ENSP00000359297.3 | 7 | MANE Select | |
| RefSeq | NP_001123237.1 | 7 | Standard | |
| RefSeq | NP_001428028.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid biosynthesis - Homo sapiens (human)
- Simvastatin Action Pathway
- Pravastatin Action Pathway
- Atorvastatin Action Pathway
- Hyper-IgD syndrome
Biological Process
- hair follicle development
- cholesterol biosynthetic process
- smoothened signaling pathway
- cholesterol metabolic process
- oxidation-reduction process
Molecular Function
- C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity
- 3-beta-hydroxy-delta5-steroid dehydrogenase activity
- oxidoreductase activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
- sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- lipid droplet
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370274
- Coding exons
- 7
- Length
- 38763
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.869 | 124 | 154 | 0.803 | 0.0000124 | 2453 |
| Missense (PolyPhen) | 22 | 50.608 | 0.43471 | 827 | ||
| Synonymous | -1.02 | 74 | 63.7 | 1.16 | 0.00000545 | 740 |
| Loss of Function | 2.98 | 0 | 10.3 | 0.00 | 7.28e-7 | 179 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the sequential removal of two C-4 methyl groups in post-squalene cholesterol biosynthesis. {ECO:0000269|PubMed:14506130}.;
- Disease
- DISEASE: CK syndrome (CKS) [MIM:300831]: A disorder characterized by mild to severe cognitive impairment, seizures, microcephaly, cerebral cortical malformations, dysmorphic facial features, and thin body habitus. {ECO:0000269|PubMed:21129721}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- RVIS EVS
- -0.2
- RVIS percentile EVS
- 38.98
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.655
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |